E Fund Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,177
| Closed | -$41.6K | – | 372 |
|
|
2024
Q2 | $41.6K | Sell |
10,177
-3,906
| -28% | -$16K | ﹤0.01% | 318 |
|
|
2024
Q1 | $222K | Sell |
14,083
-5,257
| -27% | -$82.9K | 0.01% | 326 |
|
|
2023
Q4 | $293K | Buy |
19,340
+9,033
| +88% | +$137K | 0.02% | 232 |
|
|
2023
Q3 | $207K | Sell |
10,307
-3,185
| -24% | -$64K | 0.02% | 254 |
|
|
2023
Q2 | $381K | Buy |
13,492
+1,671
| +14% | +$47.2K | 0.03% | 181 |
|
|
2023
Q1 | $203K | Sell |
11,821
-195
| -2% | -$3.35K | 0.01% | 298 |
|
|
2022
Q4 | $242K | Sell |
12,016
-612
| -5% | -$12.3K | 0.02% | 267 |
|
|
2022
Q3 | $274K | Sell |
12,628
-1,728
| -12% | -$37.5K | 0.03% | 247 |
|
|
2022
Q2 | $403K | Buy |
14,356
+8,277
| +136% | +$232K | 0.04% | 188 |
|
|
2022
Q1 | $280K | Buy |
+6,079
| New | +$280K | 0.01% | 224 |
|